logo
Sign in

CENTERLINE BIOMEDICAL INC

Cleveland, OH · Medtech · Private

Real-time surgical navigation technology that reduces radiation exposure during interventional procedures

Claim this profile

Follows are private to you and power your alerts

Updated · centerlinebiomedical.com

Sector
Medtech
Headquarters
Cleveland, OH
Latest Form D
$10.8M, Apr 2025
Total capital
$78.6M
Federal grants
$6.8M
10 awards · 2018–2021
Rank in peer group#281 of 538
Private capital raised
$71.8M
4 Form D · last Apr 2025
18 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
10
12 pending · first 2021
Rank in peer group#61 of 538

Capital timeline

20182019202020212022202320242025FEDERAL ↑EQUITY ↓Cumulative $78.6M$667K$1.5M$1.5M$807K$847K1st Form D$34.7M4th Form D$10.8M
2018202020222024FEDERAL ↑EQUITY ↓Cumulative $78.6M$1.5M$1.5M$847K1st Form D$34.7M

Latest events

  • Private capital raisedForm D · SEC · 4th filing$10.8M
  • Private capital raisedForm D · SEC · 3rd filing$13.7M
  • Private capital raisedForm D · SEC · 2nd filing$12.7M
  • Private capital raisedForm D · SEC · 1st filing$34.7M
  • Federal grantHealth and Human S · Phase II · IOPSxV: Novel Visualization for Non-Fluoroscopic 3D Image Guidance for Peripheral Vascular Interventions.$847K
  • Federal grantHealth and Human S · Phase II · 3D Holographic Guidance, Navigation, and Control (3D GN&C) for Endovascular Aortic Repair (EVAR)$807K
  • Federal grantHealth and Human S · Phase II · IOPSxV: Novel Visualization for Non-Fluoroscopic 3D Image Guidance for Peripheral Vascular Interventions.$1.5M
Show 7 earlier federal awards
  • Federal grantHealth and Human S · Phase II · IOPSxV: Novel Visualization for Non-Fluoroscopic 3D Image Guidance for Peripheral Vascular Interventions.$637K
  • Federal grantHealth and Human S · Phase II · 3D Holographic Guidance, Navigation, and Control (3D GNandC) for Endovascular Aortic Repair (EVAR)$1.5M
  • Federal grantHealth and Human S · Phase II · 3D Holographic Guidance, Navigation, and Control (3D GN&C) for Endovascular Aortic Repair (EVAR)$667K
  • Federal grantHealth and Human S · Phase I · 4D Holographic Guidance for Transfemoral Aortic Valve Replacement (TAVR)$225K
  • Federal grantHealth and Human S · Phase I · 4D Holographic Guidance for Transfemoral Aortic Valve Replacement (TAVR)$225K
  • Federal grantHealth and Human S · Phase I · 3D Holographic Guidance, Navigation, and Control (3D GN&C) for Endovascular Aortic Repair (EVAR)$224K
  • Federal grantHealth and Human S · Phase I · 3D Holographic Guidance, Navigation, and Control (3D GN&C) for Endovascular Aortic Repair (EVAR)$224K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Federal first

69months

from CENTERLINE BIOMEDICAL INC’s first federal award to its first private round.

First federal award · Feb 2018
Health and Human S · $224K
First Form D · Nov 2023
$34.7M · 1st Form D
Awards before first raise
10 awards

An association in public records, not a cause or a prediction.

Standing among 538 peers

Line = median

Medtech · Device

  • Federal grantsBelow median
  • Granted patents#61 · top 11%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Vikash K. GoelResearcherExecutive OfficerLinked by $6.4M in grants as PI
  • Akhil SaklechaDirectorNamed in SEC Form D filings
  • Arnaud MarieDirectorNamed in SEC Form D filings
  • Gulam KhanExecutive OfficerNamed in SEC Form D filings
  • Indrani EglestonExecutive OfficerNamed in SEC Form D filings
  • Jai N. GuptaDirectorNamed in SEC Form D filings
Show all 13 people
  • Jim ZalarDirectorNamed in SEC Form D filings
  • Karen ShanahanDirectorNamed in SEC Form D filings
  • Michael WhitmanDirectorNamed in SEC Form D filings
  • Mitch WolfDirectorNamed in SEC Form D filings
  • Phil RackliffeExecutive Officer, DirectorNamed in SEC Form D filings
  • Todd SchwarzingerDirectorNamed in SEC Form D filings
  • Vinod K. GoelExecutive Officer, DirectorNamed in SEC Form D filings

What it has protected

USPTO · 10 granted of 22
Show all 22 patent records

Related companies, and why

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .